WELCOME TO The HEALTHCARE REPORT
Health Plus Limited
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Eyenuk, Inc. | December 08, 2021
Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™ and AI Predictive Biomarkers™, announces today that Discovery Health launched a new Diabetic Retinopathy Screening Benefit nationwide in South Africa, powered by the cutting-edge EyeArt® AI System helping enable the detection of the onset of diabetic retinopathy as early as possible.
By launching the new Diabetic ...
InterGen Data, Inc | October 18, 2021
InterGen Data, Inc., a leading provider of Life Event Data, analytics, and predictive modeling, has signed Spectrum Health Solutions “Spectrum” as a new client. Spectrum will utilize InterGen Data’s predictive data to analyze and identify when their patients are likely to have Chronic Illnesses occur, what they might be, and how much they are projected to cost. Spectrum will further use InterGen’s data to help them assess new patient populations as they expand their se...
Healthcare IT News | February 18, 2020
Cerner and its longtime client Intermountain Healthcare have announced a multiyear expansion of their technology partnership, and say they'll continue to innovate ways to boost quality, safety, and patient and provider experience. Intermountain has deployed an array of Cerner products across its two-dozen hospitals and 210 clinics to drive better outcomes and control costs. In a blog post, Cerner says the expansion will enable it to "continue to increase the speed of innovation and help...
Revibe technologies | February 09, 2022
Revibe technologies, a commercial-stage digital therapeutics company, announced today the positive results of their feasibility study examining the efficacy of FokusRx in school aged children with attention deficit hyperactivity disorder (ADHD). FokusRx is an investigational SaMD (Software as a Medical Device) that has the potential to provide a new nonpharmacologic approach to treating attention, focus and hyperactivity deficits associated with ADHD, and other mental health conditions.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE